Condition
NK-LGL Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 5 NK-LGL Leukemia clinical trials that are recruiting, at sites in 2 countries (most in China (4), Germany (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest NK-LGL Leukemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| National longitudinal cohort for large granular lymphocytic leukemia (LGLL) | — | Tianjin, Tianjin Municipality | Recruiting | Jun 13, 2025 |
| Golidocitnib treatment for relapsed indolent T/NK-cell lymphomas | Phase 2 | Tianjin, Tianjin Municipality and 1 other locations | Recruiting | Dec 4, 2024 |
| Thalidomide treatment for symptomatic large granular lymphocytic leukemia | Phase 2 | Tianjin, Tianjin Municipality | Recruiting | Jul 31, 2024 |
| Using PI3K inhibitors to treat relapsed indolent T/NK-cell lymphomas | Phase 2 | Tianjin, Tianjin Municipality | Recruiting | Jul 31, 2024 |
| Registry for patients with chronic lymphocytic leukemia and related conditions | — | Dresden, Saxony | Recruiting | Aug 11, 2016 |
All recruiting trials (5)
-
National longitudinal cohort for large granular lymphocytic leukemia (LGLL)
This project will collect past and ongoing medical data to test what factors affect diagnosis, treatments, and outcomes for people in China with T-LGL or NK-LGL leukemia.
-
Golidocitnib treatment for relapsed indolent T/NK-cell lymphomas
This study is testing if a new oral medication called Golidocitnib can help people with relapsed indolent T/NK-cell lymphomas feel better after other treatments haven't worked.
-
Thalidomide treatment for symptomatic large granular lymphocytic leukemia
This study is testing if thalidomide can help people with symptomatic large granular lymphocytic leukemia feel better by seeing how well it works on its own.
-
Using PI3K inhibitors to treat relapsed indolent T/NK-cell lymphomas
This study is testing if two new oral medications can help people with relapsed indolent T/NK-cell lymphomas feel better and improve their treatment options.
-
Registry for patients with chronic lymphocytic leukemia and related conditions
This study is tracking patients with chronic lymphocytic leukemia and similar conditions to see how well different treatments work and what long-term effects they might have.
Related topics
Quick answers
How many NK-LGL Leukemia clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (4 trials), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.